An enzyme linked immunosorption assay for tissue factor pathway inhibitor

Area of Science:

• Biochemistry
• Immunology
• Assay Development

Background:

• Tissue factor pathway inhibitor (TFPI) is a critical regulator of the coagulation cascade.
• Accurate quantification of TFPI is essential for understanding its role in hemostasis and thrombosis.
• Existing assays may have limitations in detecting specific TFPI forms or complexes.

Purpose of the Study:

• To develop and validate a robust enzyme-linked immunosorbent assay (ELISA) for quantifying full-length and carboxy-terminus truncated human TFPI.
• To assess the assay's sensitivity, specificity, reproducibility, and normal reference range.

Main Methods:

• Development of a two-antibody sandwich ELISA using a monoclonal capture antibody and a polyclonal detection antibody.
• Characterization of assay performance, including sensitivity, linearity, and detection limits.
• Determination of TFPI levels in plasma from normal human donors and assessment of reproducibility.

Main Results:

• The developed ELISA accurately quantifies full-length and carboxy-terminus truncated TFPI with intact Kunitz-type domain 3.
• Linear reference curves were obtained in the 5-100 ng/ml range, with a normal plasma range of 7.8-26.0 ng/ml.
• The assay demonstrated high reproducibility (5.6-5.9% RSE) and good agreement with a commercial ELISA.

Conclusions:

• A robust, reproducible, and convenient ELISA assay for determining full-length and three-domain TFPI has been successfully developed.
• This assay is suitable for clinical and research applications requiring accurate TFPI quantification.
• The assay provides a reliable method for assessing TFPI levels in human plasma.